Green Cross

company

About

Green Cross is a bio pharmaceutical company headquartered in Yongin, South Korea.

  • 1001 - 5000

Highlights

Details

Industries
Biotechnology,Health Care,Sustainability
Founded date
Nov 1, 1969
Number Of Employee
1001 - 5000
Operating Status
Active

Green Cross continues to build on a long legacy of providing life-saving and life-sustaining specialty therapeutics. Their bioscience division began its business in 1971 as producing plasma-derived biotherapies for the first time in Korea. For more than 40 years, they have specialized in providing biotherapeutics to improve the quality of life for people with rare and serious diseases worldwide. Their vaccine business develops and produces paediatric and adult vaccine against a broad range of infectious diseases, from world’s 3rd hepatitis B vaccine to quadrivalent influenza vaccine.

With their mission to improve health and well-being of people around the world, they have gone down a path that nobody wishes to explore. Their extensive research and development of innovative medicines that support treatment and prevention as well as cures for diseases in a wide range of therapeutic areas demonstrate their ongoing commitment to all people who rely on their products.

Investments

Number of Investments
Number of Lead Investments
2
0
Green Cross has made 2 investments. Their most recent investment was on Nov 20, 2018, when Genoplan raised $1M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 20, 2018 Genoplan
Series B $1M Artificial Intelligence
Jun 29, 2018 Genoplan
Series B $14M Artificial Intelligence